Colchicine therapy in transcatheter aortic valve replacement: Modulating inflammation and outcomes.

Int J Cardiol Cardiovasc Risk Prev · 2026 · PMC12874275 · PMID 41658964

Europe PMC DOI

hedged sentence

0.1070

closest p · 2.1× alpha

0.1070

boldest claim

The sentences

did not reach statistical significancep = 0.107not close (p > 0.1)

The results showed a lower incidence of conduction disturbances requiring the implantation of a PPM in the colchicine group (8.3 %) compared to the placebo group (18.3 %), however, this reduction did not reach statistical significance (p = 0.107). 15 % of patients in the placebo group and 3.3 % of patients in the colchicine group had a pacemaker rhythm in the electrocardiogram at 30 days (p = 0.029).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.